Conclusion
In patients with severe acute respiratory disease associated with SARS-CoV-2, invasive aspergillosis should be suspected in case of clinical worsening, even in immunocompetent patients. At the same time, aspergillosis should not be forgotten in patients with worsening after steroid and immunomodulator therapy.
Pulmonary aspergillosis is a severe complication of COVID-19 patients that may not respond well to medical therapy. Pulmonary resection is the most effective treatment to control the disease.